OverviewChartNewsTraderScreen

REGENXBIO/  US75901B1070  /

IEX
14/06/2024  21:59:47 Chg. -0.72 Volume Bid- Ask- High Low
12.35USD -5.51% 8,687
Turnover: 109,104.55		 -Bid Size: - -Ask Size: - 13.02 12.35
GlobeNewswire 12/06 Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at t...
GlobeNewswire 01/05 Gene Therapies in Degenerative Retinal Disease Hold Potential to Capture Significant Portion of Mark...
GlobeNewswire 29/04 Coave Therapeutics Showcases its ALIGATER™ Platform for Generating Conjugated AAV (coAAV) Vectors Ex...
GlobeNewswire 08/02 Stakes Are High for Regeneron's Eylea HD as Genentech's Vabysmo Continues to Gain Momentum, Promptin...
GlobeNewswire 13/11/2023 Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire 07/11/2023 Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic In...
GlobeNewswire 12/10/2023 Coave Therapeutics appoints Leading World Experts to newly formed Scientific Advisory Board dedicate...
GlobeNewswire 10/03/2022 Clearside Biomedical Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corp...
GlobeNewswire 14/02/2022 Clearside Biomedical’s Suprachoroidal Injection Platform Featured at the Angiogenesis, Exudation, an...
GlobeNewswire 10/02/2022 Ultragenyx Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
GlobeNewswire 02/02/2022 Clearside Biomedical’s Suprachoroidal Injection Platform to be Featured at the Angiogenesis, Exudati...
GlobeNewswire 22/12/2021 Abeona Therapeutics Issues Letter to Shareholders
GlobeNewswire 16/11/2021 Clearside Biomedical Features FDA-Approved XIPERE™ in Multiple Presentations at the American Academy...
GlobeNewswire 15/11/2021 Abeona Therapeutics Reports Third Quarter Financial Results
GlobeNewswire 10/11/2021 Clearside Biomedical Announces Third Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire 03/11/2021 Solid Biosciences Provides Third Quarter 2021 Business Update and Financial Results
GlobeNewswire 02/11/2021 Ultragenyx Reports Third Quarter 2021 Financial Results and Corporate Update
GlobeNewswire 02/11/2021 Pathway Development Consortium Releases Draft White Paper to Facilitate AAV Gene Therapy Development
GlobeNewswire 13/10/2021 Clearside Biomedical Delivers Podium and Poster Presentations at the American Society of Retina Spec...
GlobeNewswire 04/10/2021 Clearside Biomedical Announces Multiple Poster Presentations at the Retina Society 54th Annual Scien...
GlobeNewswire 02/08/2021 Ultragenyx Reports Second Quarter 2021 Financial Results and Corporate Update
GlobeNewswire 22/06/2021 uniQure to Acquire Corlieve Therapeutics and Advance its Gene Therapy Program to Treat Temporal Lobe...
GlobeNewswire 24/05/2021 Excision BioTherapeutics Appoints Biotechnology Development and Manufacturing Veteran, Franz Gerner,...
GlobeNewswire 18/05/2021 Abeona Therapeutics Reports First Quarter Financial Results
GlobeNewswire 04/05/2021 Ultragenyx Reports First Quarter 2021 Financial Results and Corporate Update